Aim of project:
To create an algorithm for FISH and karyotype testing
for plasma cell myeloma specimens to optimize
results based on (1) CD138 enrichment; (2) quantity
of clonal plasma cells; and (3) quantity of specimen.

Background of project:
Plasma cell myeloma prognosis and treatment is
significantly impacted by the identification of specific
abnormalities, typically identified by fluorescence
in-situ hybridization (FISH) and karyotype analysis.
However, limitations with regard to quantity of
clonal plasma cells and quantity of specimen exist.
A uniform and algorithmic approach to plasma cell
myeloma specimen processing with testing tailored to
plasma cell concentration and specimen volume may
(1) reduce unnecessary testing; (2) improve diagnostic
yield; and (3) yield significant cost savings.

Planned intervention tested
An algorithmic approach has been developed for
use in our department with regard to specimen
triaging based on (1) the presence clonal plasma cells;
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(2) plasma cell concentration of specimen; and (3)
quantity of specimen. A 6-month retrospective review
was performed that identified all cases with clonal
plasma cells. Metrics for our study included number
of cases where: (1) cytogenetic testing was unnecessarily performed on cases without clonal plasma
cells; (2) cases with > 30% clonal plasma cells where
purification methods were unnecessarily used and/
or appropriate cytogenetic stimulation was not used;
and (3) cases with <30% clonal plasma cells where
appropriate specimen triage was not followed. A
6-month prospective analysis of these metrics will be
reviewed following the implementation of our newly
developed “Algorithm for Myeloma Testing.”

Prediction of Results and/or Intended Results:
The goals of the intervention were to standardize the
approach to plasma cell myeloma FISH and karyotype
testing within our laboratory. We anticipate (1)
reduction in unnecessary testing and (2) improvement
in diagnostic yield. Given the cost of testing, we
further anticipate (3) an overall cost-savings to our
organization as a result of this quality improvement.
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